Dr. Karen Leah Friedlein is a Clive, Iowa based female podiatrist who is specialized in Podiatry. Active license number of Dr. Karen Leah Friedlein for Podiatry is 00624 in Iowa. Dr. Karen Leah Friedlein is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. She diagnose and treat foot diseases and deformities. She can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Dr. Karen Leah Friedlein speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Female
Practice Address:
1701 Campus Dr Ste Ofc, Clive, Iowa, 50325-7044
Phone:
515-457-1111
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1124895545
NPI Enumeration Date:
06 Dec, 2023
NPI Last Update On:
06 Dec, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Karen Leah Friedlein are as mentioned below.
License Number
Specialization
State
Status
00624
Podiatry
Iowa
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2406 Forest St, Carroll, Iowa
Zip:
51401-3451
Phone Number:
712-830-1160
Fax Number:
--
Patients can reach Dr. Karen Leah Friedlein at 1701 Campus Dr Ste Ofc, Clive, Iowa or can call to book an appointment on 515-457-1111. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.